Project Grant K25HL175208
Award Date
8/16/24
Completion Date
7/31/29
Dollars Obligated
$181K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), totaling $742,323, supports research to develop a novel aortic valve prosthetic made from pulmonary visceral pleura (PVP) tissue. The key objectives are to evaluate the mechanical properties, hemodynamics, and long-term durability of the PVP aortic valve through in vitro experiments, computational modeling, and in vivo animal studies. The...
This $1,927,989 federal Project Grant award was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to the Research Institute at Nationwide Children's Hospital. The award supports research to understand the mechanisms and develop novel therapies for congenital aortic valve disease, a common cardiovascular condition affecting 2.5% of the U.S. population. The research aims to utilize a new mouse model that recapitulates...
This $649,992 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) supports research to investigate the mechanics and structure of aortic valve leaflets and the formation of microcalcifications, which contribute to calcific aortic valve disease. The research team at the University of Wisconsin-Madison will develop new methods to measure spatially-varying material properties of aortic valve leaflets over time, and use advanced imaging to study the...
This $148,568 federal Project Grant awarded by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the role of inflammation and sex-specific differences in the progression of aortic valve stenosis (AVS). The key objectives are to: 1) delineate how secreted factors from valve cells impact macrophage phenotype and vice versa in a sex-dependent manner, and 2) elucidate sex-specific differences in AVS...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $267,310 to The Trustees of the University of Pennsylvania to conduct research on the role of hemodynamic forces and transcription factors KLF2 and KLF4 in regulating mature cardiac valve homeostasis. The research aims to characterize how hemodynamic forces maintain valve homeostasis, identify targets of valve endothelial cell KLF2/4, and determine if...
The National Science Foundation (NSF) has awarded a $455,718 Faculty Early Career Development (CAREER) Project Grant to Marquette University to develop a living, tissue-engineered heart valve substitute capable of growing with child recipients of congenital heart valve defects. The 5-year project, funded under the NSF Engineering program (CFDA 47.041), aims to create a durable, hydrodynamically functional heart valve using an origami-inspired design and patient-derived cells that can self-repair...
The University of Colorado was awarded a $1,944,807 Project Grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to investigate the role of inflammation and biological sex on aortic valve fibrocalcification. The project aims to develop sex-specific in vitro models to study the mechanisms underlying sex differences in the progression of aortic valve stenosis, a common cardiovascular condition. Key research activities include investigating the...
The National Heart Lung and Blood Institute (NHLBI) awarded a $810,650 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Cedars-Sinai Medical Center. The funding will support the development and validation of an artificial intelligence (AI)-enabled algorithm to characterize fibrotic and calcific aortic valve tissue from computed tomography angiography (CTA) scans. The goal is to predict rapid aortic valve disease progression and create an AI-powered risk score to predict...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $207,015 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Children's Hospital Medical Center in Cincinnati, Ohio. The grant project, titled "Effects of Early Retinoic Acid Signaling on Valve Development", aims to elucidate the role of retinoic acid signaling in the early development of cardiac valves. The research will test hypotheses related to how retinoic acid signaling establishes...
This $750,345 Project Grant award was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Pittsburgh. The funding supports research to investigate the role of telomerase reverse transcriptase (TERT) in the osteogenic reprogramming of aortic valve interstitial cells, which can lead to calcific aortic valve disease. The project aims to elucidate the epigenetic and transcriptional changes directed by...